The 2005 National French Adverse Event Study: ENEIS

15
11.05.2006 SCIENTIFIC CONFERENCE : PATIENT SCIENTIFIC CONFERENCE : PATIENT SAFETY AND QUALITY ASSURANCE SAFETY AND QUALITY ASSURANCE The 2005 National French Adverse The 2005 National French Adverse Event Event Study Study : ENEIS : ENEIS Anne Farge - Broyart Ministry of Health Hospitalization and health care organization department Madrid - May 11 th 2006

description

The 2005 National French Adverse Event Study: ENEIS. Anne Farge – Broyart. Presentation of the National Study of Adverse Events (Madrid, Ministry of Health and Consumer Affairs, 2006)

Transcript of The 2005 National French Adverse Event Study: ENEIS

Page 1: The 2005 National French Adverse Event Study: ENEIS

11.05.2006

SCIENTIFIC CONFERENCE : PATIENT SCIENTIFIC CONFERENCE : PATIENT SAFETY AND QUALITY ASSURANCESAFETY AND QUALITY ASSURANCE

The 2005 National French AdverseThe 2005 National French Adverse Event Event StudyStudy : ENEIS: ENEIS

Anne Farge - BroyartMinistry of HealthHospitalization and

health care organization department

Madrid - May 11 th 2006

Page 2: The 2005 National French Adverse Event Study: ENEIS

11.05.2006

The Adverse Event (AE) French national study

A first national study- The Ministry of Health needed data on serious adverse events to

implement patient safety policy- The department of Research, Studies, Evaluation and Statistic

(DREES) set up the study called “ENEIS”Objectives of ENEIS

- To estimate the incidence of serious adverse events (AE) in medical and surgical activities in public and private hospitals

- To assess the patient clinical situation and the active errorsDesign

Prospective assessment of AE by senior nursing and doctor external investigators with ward staffCoordination

A regional network - Committee on coordination and clinical evaluation anquality in Aquitaine (CCECQA ) with 6 regional teams

Page 3: The 2005 National French Adverse Event Study: ENEIS

11.05.2006

Page 4: The 2005 National French Adverse Event Study: ENEIS

11.05.2006

Incidence of AE during hospitalization

6,6 AEs / 1000 days (1 every 5 days in a 30 bed ward)

37% preventable

32,9149 7,0 [5,8 ; 8,3] Surgery

37,2255 6,6 [5,7 ; 7,5]Total

43,4106 6,2 [4,9 ; 7,5] Medicine

% PreventableAEs

Total AEsNumber ‰ [CI 95%]

Page 5: The 2005 National French Adverse Event Study: ENEIS

11.05.20060 5 10 15 20 25 30 35 40 45

Respiratory tract

Digestive tract

Heart

Vessels

Nephro-urologic system

Skin

Multi-organ disorder

Psychological disorder

Electrolytic disorder

Nervous system

Locomotor system

Genitourinary system

Ophtalmologic system

ENT system

Pain

Haematological disorder

Psychiatric disorder

Endocrine system

Stomatologic disorder

Preventable

Non preventable

Number of AE identified during hospitalization according to preventability and to anatomic location

Page 6: The 2005 National French Adverse Event Study: ENEIS

11.05.2006

Inhalation pneumopathy during anaesthetic induction for oesophagal diverticulum in a man 48 yrs

4

Pneumothorax in a male patient 51 yrs hospitalised for pneumonectomy (aspergillosis on tubercular sequellae) occurring subclavian catheterisation

5

Stomach lesion during nephrectomy via celioscopy, requiring subsequent open surgery in woman 59 yrs

4

Perforation of the colon during colonoscopy in a man 73 yrs 4 Dissatisfaction of patient 57 yrs and hospitalisation for endoscopic retrograde cholangiopancreatography under general anaesthetic delayed on account of a leak in the endoscope discovered once the patient was anaesthetised

6

Patient 79 yrs dissatisfied after discharge was delayed; patient hospitalised for spontaneous haematoma of the left intracranial haemorrhage, waited 25 days for a control scan which was never actually performed. Communication problem between hospitalisation departments and imagery departments.

4

Lumbar pain in connection with second lumbar vertebra fracture non diagnosed in emergency unit, delay in diagnosis and corset fitted, man 20 yrs.

4

Hospitalisation for acute sigmoiditis and varicose ulcer treatment in a female patient 96 yrs. Intense systematic pain during care procedures despite preventive treatment (15mg morphine in subcutaneous administration).

4

AE during hospitalization and preventabibity score

Page 7: The 2005 National French Adverse Event Study: ENEIS

11.05.2006

Incidence of hospital admission caused by AEs

4% of admissions caused by AEs

45% Preventable

35,896 3,5 [2,7 ; 4,3] Surgery44,7191 3,9 [3,3 ; 4,6]Total

53,895 4,5 [3,5 ; 5,6] Medicine

% PreventableAEs

Total AEsNumber % [IC à 95%]

Page 8: The 2005 National French Adverse Event Study: ENEIS

11.05.2006

AE leading to hospitalization and preventabibity score

Demented female patient 85 yrs hospitalised for cognitive disorders. Recently instated treatment for arthritic pain causing confusion; improvement after dose adjustment

4

Ischaemic CVA in a female patient 61 yrs under long-term anticoagulants (mitral prosthesis). Preventive treatment dosage too low (INR=2,87 (expected value between 3,5 and 4,5) from10 days prior to hospitalisation)

4

Hospitalisation of a child, on parents’ initiative, for pneumococcal meningitis on 4th day of fever, following consultations with GP who diagnosed upper respiratory tract infection

6

Admission of female patient 80 yrs for confusion syndrome aggravated by 3 changes in wards in 4 days. Initial hospitalisation for dislocated shoulder

4

Woman 22 yrs admitted to intense care for meningitis following subarachnoid anaesthesia during childbirth

5

Infection of the operative site, abscess at port of entry and arthritis of the knee; septicaemia following removal of osteo-synthetic material on the tibia in a male patient 48 yrs with no particular comorbidity

4

Displacement of a fracture of the radius in plaster in a child 10 yrs 4 Stiffness after total prosthesis of the knee, in connection with insufficient physiotherapy at home, female patient 78 yrs

5

Hospitalisation of a woman 76 yrs for haematemesis and melaena in connection with grade A oesophagitis, gastritis and stomal peptic ulcers following anti-inflammatory and anticoagulant treatment instated 2 weeks previously after intervention for dual malleolus fracture. Preventive treatment with proton pump inhibitors (PPI) initially prescribed but discontinued too early

5

Acute pancreatitis and partial colic necrosis following endoscopic sphincterectomy for choledocolitheasis in a man 33 yrs

4

Page 9: The 2005 National French Adverse Event Study: ENEIS

11.05.2006

Main exposure or mechanism

% of hospital stays arising from at least one preventable AE

Incidence density of AE during

hospitalisation

n % n ‰ Invasive procedure 32 0,76 56 1,40

- among them, surgical procedure 23 0,58 39 1,00

Healthcare product 44 0,90 30 0,70

- among them, medications 36 0,78 22 0,48

Care-related infection 18 0,37 17 0,41

- among them, wound infection 6 0,16 1 0,02

Page 10: The 2005 National French Adverse Event Study: ENEIS

11.05.2006

Type of active error (% of AE)

All AE (n=450)

Preventable AE (n=181)

No error 49 24

Failure to adequately implement care 18 35

Failure to choose appropriate care 8 17

Delay in implementing care 8 17

Don’t know 18 8

Page 11: The 2005 National French Adverse Event Study: ENEIS

11.05.2006

Contributory factors (45 root cause analysis)

0 2 4 6 8 10 12 14 16 18 20

Conflicts

Outside area of expertise

Betw een HCO coordination

Stress

Building

Safety culture

Task planif ication

Know ledge, attitude

Definition of responsability

f inancial shortage

Betw een w ards coordination

Facing unexpected situation

Equipment/supply

Reporting, coordination

Delay/availability of information

Workload, staff supervision

Communication w ith patient/familiy

Clinicalprotocol/policy

Weakly associatedStrongly associated

Page 12: The 2005 National French Adverse Event Study: ENEIS

11.05.2006

Contributary factors as pathways for occurrence of preventable AE

PrevAE

Individual clinical team tasks environment organisation institution

Page 13: The 2005 National French Adverse Event Study: ENEIS

11.05.2006

Key points

WhatWhat??

40% of AE preventable

seriousness : 40% of AE = only prolongation

of hospitalization

≥1 AE occured in 2/3 of the wards for a

seven 7 days

Patient : 2/3 withcomplex medical

status

2/3 of the AE during ahospital stay

Who Who ??WhereWhere??

Page 14: The 2005 National French Adverse Event Study: ENEIS

11.05.2006

http://www/drees/publica/indexpub.htm

Page 15: The 2005 National French Adverse Event Study: ENEIS

11.05.2006

Next steps

A national serious adverse events reportingsystem to build- A mandatory system : law of August 9th 2004 (loi de santépublique)- Hospital and primary care- A three year experimentation period before implementation

October 2005 : a meeting on serious healthadverse events and reporting system

http://www.sante.gouv.fr/htm/dossiers/risques_etabs/accueil.htm